Company Profile
Updated: 17-SEP-09Leerink Swann and Company Inc.
Private Company, Headquarters Location
1 Federal St., 37th Fl., Boston, MA 02110-2028, United States
(800)808-7525, (617)248-1601, (617)918-4900 fax, http://www.leerink.com
Primary SIC: Management Investment, Open-end, Primary NAICS: Open-End Investment Funds
Description: Finance: Investment banking. Services: Biomedical consulting to life sciences companies and the investment community.
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
Dendreon Announces Pricing of Common Stock Offering.
Medical Letter on the CDC & FDA; 12/27/2009; 1188 words; ...P. Morgan Securities Inc. and Deutsche Bank Securities Inc. acted as joint book...Citigroup Global Markets Inc., Morgan Stanley & Co...Lazard Capital Markets LLC, Leerink Swann LLC and Needham & Company, LLC acted as co-managers...
Myriad Snags Late-Stage Drug in All-Stock Javelin Acquisition.
BIOWORLD Today; 12/21/2009; 864 words; ...Pharmaceuticals Inc. is buying...Pharmaceuticals Inc. in an all...the combined company - that could...investor on the companies' joint conference...Shareholders of both companies have to approve...preserves the company's cash...either. But Leerink Swann analyst ...
AVEO Files $86M IPO to Support New Phase III Kidney Cancer Trial.
BIOWORLD Today; 12/18/2009; 1290 words; ...Cumberland Pharmaceuticals Inc. and Talecris Biotherapeutics...the wings. Drug companies with IPO paperwork...Ironwood Pharmaceuticals Inc., antibiotic company Trius Therapeutics Inc., ophthalmology...Co. Inc., with Leerink Swann LLC serving as lead...
Auxilium shares fall on Xiaflex study results
AP Online; 12/16/2009; 696 words; ...Auxilium Pharmaceuticals Inc. fell Wednesday...penile curvature. The company said the drug candidate...placebo. Still, the company said there were no...Malvern, Pa., company is waiting for an...s contracture. Leerink Swann Research analyst...
Auxilium drug meets penile curvature study goal
AP Online; 12/16/2009; 712 words; ...Auxilium Pharmaceuticals Inc. said Wednesday...penile curvature. The company said the drug candidate...placebo. Still, the company said there were no...Meanwhile, the company is waiting for an...the last 52 weeks. Leerink Swann Research analyst...
Recent News Articles
- ANALYST INTERVIEW: OUTLOOK FOR HOSPITALS AND HEALTH FACILITIES - ANN K. HYNES - LEERINK SWANN & COMPANY, INC.
Wall Street Transcript Digest - November 05, 2007 - ANALYST INTERVIEW: ORTHOPEDICS - JASON WITTES - LEERINK SWANN & COMPANY, INC.
Wall Street Transcript Digest - April 16, 2007 - ANALYST INTERVIEW: ACUTE CARE & POST-ACUTE SERVICE PROVIDERS - ANN K. HYNES - LEERINK SWANN & COMPANY, INC.
Wall Street Transcript Digest - February 26, 2007 - BioTrove, Inc. to Webcast Presentation at Leerink Swann & Company Roundtable Discussion.(Discussion)
Business Wire - May 01, 2006
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning